The EANM guideline on radioiodine therapy of benign thyroid disease

被引：0

作者：

Alfredo Campennì

Anca M. Avram

Frederik A. Verburg

Ioannis Iakovou

Heribert Hänscheid

Bart de Keizer

Petra Petranović Ovčariček

Luca Giovanella

机构：

[1] University of Messina,Department of Biomedical and Dental Sciences and Morpho

[2] Case Western Reserve University,Functional Imaging, Unit of Nuclear Medicine

[3] Erasmus MC,Departments of Radiology and Medicine, MetroHealth Hospital

[4] Aristotle University of Thessaloniki,Department of Radiology & Nuclear Medicine

[5] General Hospital Papageorgiou,Academic Department of Nuclear Medicine, University Hospital AHEPA, School of Medicine

[6] Aristotle University of Thessaloniki,Academic Department of Nuclear Medicine

[7] University Hospital Würzburg,Department of Nuclear Medicine

[8] University Medical Centre Utrecht,Department of Radiology and Nuclear Medicine

[9] University Hospital Center Sestre Milosrdnice,Department of Oncology and Nuclear Medicine

[10] University of Zagreb,School of Medicine

[11] Imaging Institute of Southern Switzerland,Clinic for Nuclear Medicine, Ente Ospedaliero Cantonale

[12] University Hospital and University of Zurich,Clinic for Nuclear Medicine

来源：

European Journal of Nuclear Medicine and Molecular Imaging | 2023年 / 50卷

关键词：

Graves’ disease; Toxic nodular goiter; Non-toxic goiter; RAI therapy; Fixed activity; Dosimetry;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

This document provides the new EANM guideline on radioiodine therapy of benign thyroid disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners in the selection of patients for radioiodine therapy. Its recommendations on patients’ preparation, empiric and dosimetric therapeutic approaches, applied radioiodine activity, radiation protection requirements, and patients follow-up after administration of radioiodine therapy are extensively discussed.

引用

页码：3324 / 3348

页数：24

共 928 条

[1]

Diehl LA(2005)Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey J Clin Endocrinol Metab 90 117-123

[2]

Garcia V(2000)Management of the nontoxic multinodular goitre: a European questionnaire study Clin Endocrinol (Oxf) 53 5-12

[3]

Bonnema SJ(2002)Management of the nontoxic multinodular goiter: a North American survey J Clin Endocrinol Metab 87 112-117

[4]

Hegedüs L(2003)Differences between endocrine surgeons and endocrinologists in the management of non-toxic multinodular goitre Br J Surg 90 1103-1112

[5]

Albino CC(2010)EANM procedure guidelines for therapy of benign thyroid disease Eur J Nucl Med Mol Imaging 37 2218-2228

[6]

Graf H(2021)A systematic review and meta-analysis of the relationship between the radiation absorbed dose to the thyroid and response in patients treated with radioiodine for Graves’ disease Thyroid 31 1829-1838

[7]

Bonnema SJ(2019)EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy Eur J Nucl Med Mol Imaging 46 2514-2525

[8]

Bennedbæk FN(2016)2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis Thyroid 26 1343-1421

[9]

Wiersinga WM(2007)Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials BMJ 334 514-51

[10]

Hegedüs L(2012)The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0 J Nucl Med. 53 1633-1134

← 1 2 3 4 5 6 7 8 9 10 →